Zura Bio Limited
NASDAQ:ZURABiotechnology
+$0.07 today
- Market cap
- $92.96M
- Beta
- 0.03
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$0.67
Volume 3.02M
Average 0.75M
ZURA Total Debt
Short-term and long-term borrowings combined.
Zura Bio LimitedNASDAQ: ZURA
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt remains negative
Q1 FY2026 total debt was $0, compared with $0 a year earlier.
Context
- Total debt amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Total debt increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 7.76M | — |
| FY2021 | 2022-03-31 | 0 | — |
Total Debt vs competitors
How ZURA compares with its peers on the latest reported figures
- ZURA's Mar 2026 total debt of $0 is the lowest of the 11 companies compared; the peer median is $21.12M.
- Total debt amounts to 0.0% of total assets for ZURA, versus a peer median of 8.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $3.73B | +91265.7% | -7.6% | 1.7% | |
| Mar 2026 | $186.62M | -13.7% | +96.0% | 59.3% | |
| Mar 2026 | $41.99M | +20.5% | -7.1% | 18.9% | |
| Mar 2026 | $28.87M | -1.6% | -0.3% | 16.2% | |
| Mar 2026 | $23.99M | -43.8% | -35.9% | 9.8% | |
| Mar 2026 | $18.26M | -8.0% | -0.4% | 28.4% | |
| Mar 2026 | $10.12M | -21.6% | -10.5% | 7.5% | |
| Mar 2026 | $2.49M | -17.5% | -8.8% | 1.1% | |
| Mar 2026 | $336K | -53.7% | +19.0% | 0.3% | |
SGMTSagimet Biosciences Inc. | Mar 2026 | $39K | +0.0% | -28.2% | 0.0% |
ZURAZura Bio Limited | Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding ZURA) | $21.12M | -10.8% | -7.3% | 8.6% | |
Competitors are the stored peer set for ZURA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Zura Bio Limited
NASDAQ:ZURA
Intrinsic Alpha fair value
Locked
Current Price
$0.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.